MedPath

Use of Atropine in Tredmill Stress Testing

Phase 3
Completed
Conditions
Chest Pain
Interventions
Registration Number
NCT00623207
Lead Sponsor
HaEmek Medical Center, Israel
Brief Summary

The aim of this study is to evaluate the Safety and feasibility of atropine added during treadmill stress testing in patients with chronotropic incompetence or poor exercise capacity.

Our hypothesis is that we can increase heart rate by using atropin in these patients, so we will achieve more conclusive results.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
103
Inclusion Criteria
  • Patients with chest pain without evidence of ischemia eligible for exercise test.
  • Age> 18 years old
Exclusion Criteria

Absolute:

  • Patients with LBBB
  • Unstable Angina
  • Recent Myocardial Infarction
  • Un controlled Arrythmia
  • Congestive heart faliure
  • Severe symptomatic valvular heart disease
  • Acute Pulmonary Embolism
  • Acute perimyocarditis
  • Acute aortic dissection

Relative:

  • Lt main stenosis
  • Severe hypertention (Systolic> 200 mmHg; Diastolic > 100 mmHg)
  • Cardiomyopathy
  • Obstructiove abnormalities
  • Psychiatric disorders
  • High degree AV Block

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1AtropinePateints who achieve target haert rate or conclusive test will not be given Atropine
2AtropinePatients who won't achieve tarhet heart rate or conclusive results will be given Atropine
Primary Outcome Measures
NameTimeMethod
1- To characterize patients who can't achieve target heart rate at treadmill exercise test.2- To evaluate atropine added during treadmill stress testing in order to increase heart rate and achieave conclusive test.1 yaer
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Heart Institute, Ha'Emek Medical Center

🇮🇱

Afula, Israel

© Copyright 2025. All Rights Reserved by MedPath